OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recent progress on the application of compound formulas of traditional Chinese medicine in clinical trials and basic research in vivo for chronic liver disease
Feipeng Xu, Hua Zhang, Jiamei Chen, et al.
Journal of Ethnopharmacology (2023) Vol. 321, pp. 117514-117514
Closed Access | Times Cited: 7
Feipeng Xu, Hua Zhang, Jiamei Chen, et al.
Journal of Ethnopharmacology (2023) Vol. 321, pp. 117514-117514
Closed Access | Times Cited: 7
Showing 7 citing articles:
A review of Phyllanthus urinaria L. in the treatment of liver disease: viral hepatitis, liver fibrosis/cirrhosis and hepatocellular carcinoma
Linhua Liu, Bing Wang, Yibo Ma, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Linhua Liu, Bing Wang, Yibo Ma, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Proteomic Analysis of the Ameliorative Effect of Total Flavonoids from Astragali Complanati Semen on Ccl(4)-Induced Liver Fibrosis in Rats Via the Fak/Akt1 Pathway
Lin Chen, Ruina Zhou, Xin Kong, et al.
(2025)
Closed Access
Lin Chen, Ruina Zhou, Xin Kong, et al.
(2025)
Closed Access
An analysis of the burden of liver cirrhosis: Differences between the global, China, the United States and India
Keqiang Lu, Juanjuan Sui, Wenhui Yu, et al.
Liver International (2024)
Closed Access | Times Cited: 2
Keqiang Lu, Juanjuan Sui, Wenhui Yu, et al.
Liver International (2024)
Closed Access | Times Cited: 2
Mechanistic insights of clinically proven natural products in the treatment of hepatitis B focusing on clinical evidence and pathways
Anwar Parvez, Anand Kumar Das, Ashik Mahmud, et al.
Deleted Journal (2024), pp. 200183-200183
Open Access | Times Cited: 2
Anwar Parvez, Anand Kumar Das, Ashik Mahmud, et al.
Deleted Journal (2024), pp. 200183-200183
Open Access | Times Cited: 2
Network Pharmacology Followed by Experimental Validation to Explore the Mechanism of Stigmasterol in Sangbaipi Decoction Regulating PI3K/Akt Signaling to Alleviate Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Haidong He, Shuihua Sun, Weihua Xu, et al.
International Journal of COPD (2024) Vol. Volume 19, pp. 1819-1834
Open Access | Times Cited: 1
Haidong He, Shuihua Sun, Weihua Xu, et al.
International Journal of COPD (2024) Vol. Volume 19, pp. 1819-1834
Open Access | Times Cited: 1
Desmodium styracifolium (Osb.) Merr. extracts alleviate cholestatic liver disease by FXR pathway
Zhiyuan Zhang, Guoqiang Guan, Zixuan Tang, et al.
Journal of Ethnopharmacology (2024), pp. 118972-118972
Closed Access | Times Cited: 1
Zhiyuan Zhang, Guoqiang Guan, Zixuan Tang, et al.
Journal of Ethnopharmacology (2024), pp. 118972-118972
Closed Access | Times Cited: 1
Integrated evidence chain-based effectiveness evaluation of traditional Chinese medicines (iEC-Eff): A demonstration study
Ye Luo, Xu Zhao, Ruilin Wang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 15, Iss. 2, pp. 909-918
Open Access | Times Cited: 1
Ye Luo, Xu Zhao, Ruilin Wang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 15, Iss. 2, pp. 909-918
Open Access | Times Cited: 1
